NCT02303483View on ClinicalTrials.gov

The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 4, 2016

Primary Completion Date

April 4, 2017

Study Completion Date

April 4, 2017

Conditions
Obese
Interventions
DIETARY_SUPPLEMENT

Nicotinamide riboside (NIAGEN TM, ChromaDex, CA, USA )

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

8000

Medical Research Laboratories, Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Aarhus University Hospital

OTHER

NCT02303483 - The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men | Biotech Hunter | Biotech Hunter